Gene · 4299
Papers2,225
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,225
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Statement of Retraction: Circular RNA hsa_circ_0057452 facilitates keloid progression by targeting the microRNA-1225-3p/AF4/FMR2 family member 4 axis. | Bioengineered | 2026 | 42826093 | PubTator, text mining | PubMed |
| Glycosylation-Associated Macrophage Signatures Define a Diagnostic Model for Diabetic Retinopathy via Single-Cell Analysis. | J Ophthalmol | 2026 | 42662694 | PubTator, text mining | PubMed |
| A novel KMT2A::AFF1-derived fusion circRNA regulates mitochondrial metabolism in t(4;11) B-cell acute lymphoblastic leukemia. | Haematologica | 2026 | 42610417 | PubTator, text mining | PubMed |
| Influence of IGF2BP3 on t(4;11) fusion mRNA and protein abundance. | Leuk Res | 2026 | 42537480 | PubTator, text mining | PubMed |
| Disrupting a Convergent Acetylation Circuit Collapses Leukemic Identity Across AML Subtypes. | bioRxiv | 2026 | 42523331 | PubTator, text mining | PubMed |
| The MLLT3 YEATS domain binds histone marks (H3K9/18/27ac/cr) and ncRNA (7SK), linking transcription and RNA signaling to regulate hematopoiesis. | Cell Rep | 2026 | 42268713 | PubTator, text mining | PubMed |
| Inhibition of MLLT1 Limits Growth of KMT2A::AFF1 Leukemias Without Killing Healthy Hematopoietic Stem Cells. | Exp Hematol | 2026 | 42242459 | PubTator, text mining | PubMed |
| An integrated multi-omics analysis reveals a core epigenetically-activated transcriptional network driving oncogenic signaling in acute myeloid leukemia. | Discov Oncol | 2026 | 42217088 | PubTator, text mining | PubMed |
| Multi-stage transcriptome analysis identifies hub genes and regulatory mechanisms driving cervical cancer progression. | PeerJ | 2026 | 42180604 | PubTator, text mining | PubMed |
| Characterizing the impact of MLL fusion variants and fusion partners on leukemia plasticity using a human CRISPR-engineered MLL-rearranged leukemia model. | Neoplasia | 2026 | 42001795 | PubTator, text mining | PubMed |
| Dual targeting of GPX4 and TXNRD1 triggers eradication of AML cells through induction of apoptosis and ferroptosis. | Exp Hematol Oncol | 2026 | 41917989 | PubTator, text mining | PubMed |
| A Phase 1 Prognostic Trial for Predicting Paediatric Allergy Using the Placenta at Birth. | Clin Exp Allergy | 2026 | 41795204 | PubTator, text mining | PubMed |
| A One-Step Workflow for Size-Based Separation of Extracellular Vesicles With Integrated Surface Marker Detection. | J Extracell Biol | 2026 | 41788818 | PubTator, text mining | PubMed |
| Gremlin-1 promotes leukemic survival via PI3K/AKT signaling in infant MLL-AF4-positive B-cell acute lymphoblastic leukemia. | Exp Hematol | 2026 | 41759887 | PubTator, text mining | PubMed |
| Inside the Battle Against Acute Myeloid Leukemia: Biology, Breakthroughs, and Hope. | Cells | 2026 | 41744781 | PubTator, text mining | PubMed |
| Intra-subtype heterogeneity shapes treatment response in KMT2A-rearranged ALL across all age groups. | Hemasphere | 2026 | 41743263 | PubTator, text mining | PubMed |
| Advances in Engineered Virus-Like Particles for Genome Editing and Therapy. | BioDrugs | 2026 | 41733889 | PubTator, text mining | PubMed |
| Investigation of Regulation and Binding Patterns of the Human Cathelicidin Peptide LL-37 in Complexation with Nucleic Acids, and its Impact on Neutrophil Extracellular Traps. | bioRxiv | 2026 | 41727055 | PubTator, text mining | PubMed |
| Acute leukemia during pregnancy: a single center experience with 23 cases, 2012-2022 and literature review. | Ann Med | 2026 | 41706499 | PubTator, text mining | PubMed |
| A review of treatment strategies for elderly patients with Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia. | Transl Oncol | 2026 | 41690286 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4299/papers